What's new

Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 20, Status: Authorised

Mar 26, 2025 - 12:49
 0
Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 20, Status: Authorised
Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 20, Status: Authorised
Read More

Tags:

Previous Article

A Lancia journey through time in the heart of Waterloo

Next Article

Consumer data report: what your shoppers really want from you

Related Posts

ICH M12 on drug interaction studies - Scientific guideline

ICH M12 on drug interaction studies - Scientific guideline

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 25, 2025  0

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 26, 2025  0